On the Specific Activity of Recombinant Human Growth Hormone and Its Influence on Clinical Dosage

Cheng Suyuan, Hu Yingying, Li Yijun, Kou Yazhen, Sai Wenbo

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (5) : 595-599.

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (5) : 595-599. DOI: 10.16153/j.1002-7777.2021.05.015
Rational Medication

On the Specific Activity of Recombinant Human Growth Hormone and Its Influence on Clinical Dosage

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 35(5): 595-599 https://doi.org/10.16153/j.1002-7777.2021.05.015

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉